Differential cognitive and behavioral effects of topiramate and valproate

Neurology

Volumn 60, Issue 9, 2003, Pages 1483-1488

  Meador, Kimford J ^a,c   Loring, D W ^a   Hulihan, J F ^b   Kamin, M ^b   Karim, R ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

^c GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOCAL EPILEPSY; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; RANDOMIZED CONTROLLED TRIAL; SPEECH DISORDER;

EID: 0038220938     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000063308.22506.19     Document Type: Article

References (27)

1. Reife R, Pledger G, Wu S-C. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000; 41(suppl 1):S66-71.
2. Aldenkamp AP, Baker G, Mulder OG, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-1178.
3. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999; 52:321-327.
4. Thompson PJ, Baxendale SA, Duncan JS, Sander JWAS. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000; 69:636-641.
5. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996;46:1684-1690.
6. Sharief M, Viteri C, Ben-Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996;25:217-224.
7. Willmore LJ, Shu V, Wallin B, and the M88-194 Study Group. Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. Neurology 1996;46:49-53.
8. Meador KJ, Loring DW, Allen ME, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41: 1537-1540.
9. Meador KJ, Loring DW, Abney OL, et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993;34:153-157.
10. Meador KJ, Loring DW, Moore EE, et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy subjects. Neurology 1995;45:1494-1499.
11. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999;40:1279-1285.
12. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive effects of carbamazepine and lamotrigine. Neurology 2001;56:1177-1182.
13. Ray PG, Meador KJ, Loring DW, Zamrini EY, Yang XH, Buccafusco JJ. Central anticholinergic hypersensitivity in aging. J Geriatr Psychiatr Neurol 1992;5:72-77.
14. Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia 1995;36:164-173.
15. Lachman R, Lachman JL, Butterfield EC. Cognitive psychology and information processing: an introduction. Hillsdale, NJ: Lawrence Erlbaum, 1979.
16. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995.
17. Wechsler D. Manual for the Wechsler Memory Scale-Revised. New York: The Psychological Corporation, 1987.
18. Smith A. Symbol Digit Modalities Test. Manual. Los Angeles: Western Psychological Services, 1973.
19. Golden CJ, Stroop Color and Word Test. A manual for clinical and experimental uses. Chicago: Stoelting, 1978.
20. Lorr M, McNair DM, Droppleman LF. Manual. Profile of Mood States. San Diego: Educational and Industrial Testing Service, 1971.
21. Devinsky O, Vickrey BG, Cramer J, et al. Development of the Quality of Life in Epilepsy (QOLIE) Inventory. Epilepsia 1995;36:1089-1104.
22. Meador KJ. Cognitive effects of epilepsy and of antiepileptic medications. Chapter 88. In: Wyllie E, ed. The treatment of epilepsy: principles and practice, 3rd ed. Baltimore: Williams & Wilkins, 2001:1215-1225.
23. Biton V, Edwards KR, Montouris GD, et al., and the Topiramate TPS-TR Study Group. Topiramate titration and tolerability. Ann Pharmacother 2001;35:173-179.
24. Alapati A, Faught E. Side effect profile on two different starting doses of topiramate. Epilepsia 1999;40(suppl 7):141-142.
25. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really an option? Stat Med 1991;10: 1595-1605.
26. Gilliam FG, Veloso F. Tolerability of topiramate as monotherapy in patients with recently diagnosed partial epilepsy. Epilepsia 1998; 39(suppl 6):56.
27. Privitera MD, Brodie MJ, Neto W. Topiramate, carbamazepine, and valproate in the spectrum of newly diagnosed epilepsy. Neurology 2001; 56(suppl 3):A332. Abstract.